Background: In Italy medical hashish is a prescription drug since 1998. Even although it couldn’t be thought-about a remedy as such, it’s indicated as a symptomatic therapy additionally in most cancers sufferers, to treatment iatrogenic nausea/vomiting and continual ache.
Patients and strategies: We performed a information survey about medical hashish amongst most cancers sufferers referred to 2 outpatient most cancers care facilities and a dwelling care service.
Results: From February to April 2018, 232 affected person have been enrolled; 210 sufferers have been on lively disease-oriented therapy (90.5%), whereas 22 (9.5%) not. Eighty-one p.c of the sufferers have heard about medical hashish, however solely 2% from healthcare professionals. Thirty-four p.c of responders thought of utilizing hashish to deal with a number of of their very own well being issues, particularly ache (55%). Despite that, 18% of the contributors imagine that medical hashish may have destructive results on their very own signs. Patients with excessive academic stage higher knew hashish (odds ratio = 3.52; 95% confidence interval: 1.07-11.53), and medical hashish (odds ratio = 3.21; 95% confidence interval: 1.48-6.98), when in comparison with affected person with low academic stage. Patients who have been on lively disease-oriented therapy higher knew medical hashish (odds ratio = 3.91; 95% confidence interval: 1.26-12.11) in comparison with “out of treatment” sufferers. Metastatic sufferers have been much less knowledgeable about medical hashish in comparison with sufferers on adjuvant therapy.
Conclusions: Our survey reveals that almost all of Italian most cancers sufferers know medical hashish and a third of them have thought-about utilizing hashish to deal with one (or extra) of their very own well being issues. In the similar time, they’re poorly knowledgeable and don’t are likely to ask for details about medical hashish to healthcare professionals.